fda statement bpc-157 not approved drug Survey: Half of Peptide-Users Aren't Aware of Approval Status Is BPC-157 Legal in 2026?

For multi-dose protocols, always use bacteriostatic water

Tesamorelin Tesamorelin is a clinically approved peptide known for reducing visceral fat

GLP-1 medications like semaglutide and liraglutide slow gastric emptying by 20-30% and reduce intestinal contractions, causing stool to move more slowly through the colon and become harder

BPC-157 is a peptide thats been getting a lot of attention in the wellness world for its potential support with: muscle and joint recovery inflammation support gut health tissue repair overall healing support Think of it as part of the bigger conversation around helping your body recover smarter, not harder